Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.38
Delayed Data
As of 3:59pm ET
 +0.01 / +0.73%
Today’s Change
1.20
Today|||52-Week Range
2.30
-36.41%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.37
Today’s open1.38
Day’s range1.37 - 1.40
Volume70,268
Average volume (3 months)86,912
Market cap$97.4M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+40.54%
Earnings growth (this year)-51.14%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.13%
P/E ratioNM
Price/Sales12.13
Price/Book2.96

Competitors

 Today’s
change
Today’s
% change
SYNSynthetic Biologics ...-0.02-2.95%
ZFGNZafgen Inc-0.13-3.60%
CPRXCatalyst Pharmaceuti...-0.03-2.61%
BDSIBioDelivery Sciences...-0.05-2.86%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$11.2M
Annual profit (last year)-$13.8M
Net profit margin-122.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President &
Chief Operating Officer
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs